Star Lake BioscienceZhaoqing Guangdong Balance Sheet Health
Financial Health criteria checks 5/6
Star Lake BioscienceZhaoqing Guangdong has a total shareholder equity of CN¥7.8B and total debt of CN¥3.8B, which brings its debt-to-equity ratio to 49.1%. Its total assets and total liabilities are CN¥14.3B and CN¥6.5B respectively. Star Lake BioscienceZhaoqing Guangdong's EBIT is CN¥1.4B making its interest coverage ratio 12.1. It has cash and short-term investments of CN¥2.0B.
Key information
49.1%
Debt to equity ratio
CN¥3.81b
Debt
| Interest coverage ratio | 12.1x |
| Cash | CN¥2.01b |
| Equity | CN¥7.76b |
| Total liabilities | CN¥6.54b |
| Total assets | CN¥14.31b |
Recent financial health updates
Recent updates
Why Star Lake BioscienceZhaoqing Guangdong's (SHSE:600866) Earnings Are Better Than They Seem
Nov 04
Star Lake BioscienceZhaoqing Guangdong (SHSE:600866) Seems To Use Debt Quite Sensibly
Oct 27Little Excitement Around Star Lake Bioscience Co., Inc.Zhaoqing Guangdong's (SHSE:600866) Earnings
Sep 25Star Lake BioscienceZhaoqing Guangdong (SHSE:600866) Ticks All The Boxes When It Comes To Earnings Growth
Jul 26Estimating The Intrinsic Value Of Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHSE:600866)
May 28There's No Escaping Star Lake Bioscience Co., Inc.Zhaoqing Guangdong's (SHSE:600866) Muted Earnings Despite A 26% Share Price Rise
Apr 29Financial Position Analysis
Short Term Liabilities: 600866's short term assets (CN¥5.1B) exceed its short term liabilities (CN¥4.4B).
Long Term Liabilities: 600866's short term assets (CN¥5.1B) exceed its long term liabilities (CN¥2.1B).
Debt to Equity History and Analysis
Debt Level: 600866's net debt to equity ratio (23.2%) is considered satisfactory.
Reducing Debt: 600866's debt to equity ratio has increased from 18.3% to 49.1% over the past 5 years.
Debt Coverage: 600866's debt is well covered by operating cash flow (57%).
Interest Coverage: 600866's interest payments on its debt are well covered by EBIT (12.1x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 06:10 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhi Xue Diao | Avic Securities Co., Ltd |
| Wei Liu | Haitong International Research Limited |
| Xiaohan Sun | Haitong International Research Limited |